chrX-71147775-C-T
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 1P and 8B. PP2BP4_StrongBS2
The NM_181303.2(NLGN3):c.26C>T(p.Ser9Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000746 in 1,207,227 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 4 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_181303.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NLGN3 | NM_181303.2 | c.26C>T | p.Ser9Leu | missense_variant | 2/8 | ENST00000358741.4 | |
LOC124905197 | XR_007068262.1 | n.1106+2508G>A | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NLGN3 | ENST00000358741.4 | c.26C>T | p.Ser9Leu | missense_variant | 2/8 | 5 | NM_181303.2 | A1 |
Frequencies
GnomAD3 genomes AF: 0.0000357 AC: 4AN: 111922Hom.: 0 Cov.: 23 AF XY: 0.0000293 AC XY: 1AN XY: 34096
GnomAD4 exome AF: 0.00000457 AC: 5AN: 1095253Hom.: 0 Cov.: 31 AF XY: 0.00000830 AC XY: 3AN XY: 361329
GnomAD4 genome AF: 0.0000357 AC: 4AN: 111974Hom.: 0 Cov.: 23 AF XY: 0.0000293 AC XY: 1AN XY: 34158
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jul 29, 2019 | Variant summary: NLGN3 c.26C>T (p.Ser9Leu) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant was absent in 171937 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, c.26C>T has not been found in individuals affected with Autism Susceptibility and no experimental evidence demonstrating an impact on protein function has been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as uncertain significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at